Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Nanotechnology for Treatment of Alzheimer’s and Parkinson’s Disease
Amanda Li, Joel Tyson, S.G. Patel, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Nanozymes for Regenerative Medicine
Xiaozhou Mou, Qingyuan Wu, Zheao Zhang, et al.
Small Methods (2022) Vol. 6, Iss. 11
Closed Access | Times Cited: 86
Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders
Abdul Waris, Asmat Ali, Atta Ullah Khan, et al.
Nanomaterials (2022) Vol. 12, Iss. 13, pp. 2140-2140
Open Access | Times Cited: 72
Lipid nanoparticle-mediated drug delivery to the brain
Purva Khare, Sara X. Edgecomb, Christine M. Hamadani, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114861-114861
Closed Access | Times Cited: 65
Nanozyme enabled protective therapy for neurological diseases
F. C. Cheng, Sumasri Kotha, Miao Fu, et al.
Nano Today (2024) Vol. 54, pp. 102142-102142
Closed Access | Times Cited: 29
Improved Activity of Herbal Medicines through Nanotechnology
Mayang Kusuma Dewi, Anis Yohana Chaerunisaa, Muhaimin Muhaimin, et al.
Nanomaterials (2022) Vol. 12, Iss. 22, pp. 4073-4073
Open Access | Times Cited: 58
Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
Bwalya A. Witika, Madan Poka, Patrick H. Demana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 836-836
Open Access | Times Cited: 45
Nanozyme-based strategies for efficient theranostics of brain diseases
Ran Xu, Sijie Zhang, Peixia Wang, et al.
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215519-215519
Closed Access | Times Cited: 37
Metal nanozymes with multiple catalytic activities: regulating strategies and biological applications
Qi Yang, Yuanyang Mao, Quan Liu, et al.
Rare Metals (2023) Vol. 42, Iss. 9, pp. 2928-2948
Closed Access | Times Cited: 36
Metal–Organic Frameworks‐Based Nanoplatforms for the Theranostic Applications of Neurological Diseases
Huicong Niu, Hui Bu, Jing Zhao, et al.
Small (2023) Vol. 19, Iss. 23
Closed Access | Times Cited: 35
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Jacob Deyell, Manjari Sriparna, Mingyao Ying, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2477-2477
Open Access | Times Cited: 33
Nanozymes: Potential Therapies for Reactive Oxygen Species Overproduction and Inflammation in Ischemic Stroke and Traumatic Brain Injury
Yunfan Yang, Zi-Xiang Li, Xiaochong Fan, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16450-16467
Closed Access | Times Cited: 12
Lipid and Transcriptional Regulation in a Parkinson's Disease Mouse Model by Intranasal Vesicular and Hexosomal Plasmalogen‐Based Nanomedicines
Yu Wu, Jieli Wang, Yuru Deng, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 14
Open Access | Times Cited: 8
Advanced nanomaterials for modulating Alzheimer's related amyloid aggregation
Xu Shao, Chaoren Yan, Chao Wang, et al.
Nanoscale Advances (2022) Vol. 5, Iss. 1, pp. 46-80
Open Access | Times Cited: 31
Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis
Mayuri Khot, Anika Sood, Kamatham Pushpa Tryphena, et al.
Brain Research (2023) Vol. 1815, pp. 148462-148462
Closed Access | Times Cited: 18
Nanotechnology in the diagnostic and therapy for Alzheimer's disease
Archna Panghal, S.J.S. Flora
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 3, pp. 130559-130559
Closed Access | Times Cited: 7
An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery
Francesca Susa, Silvia Arpicco, Candido Fabrizio Pirri, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 849-849
Open Access | Times Cited: 6
Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tran Nguyen Minh An, et al.
Neurochemical Research (2021) Vol. 47, Iss. 3, pp. 552-573
Closed Access | Times Cited: 39
Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments
Edoardo Scarpa, Mariafrancesca Cascione, Anna Griego, et al.
Ibrain (2023) Vol. 9, Iss. 3, pp. 298-315
Open Access | Times Cited: 14
Designing and Formulation of Nanocarriers for “Alzheimer’s and Parkinson’s” Early Detection and Therapy
Jakleen Abujamai, Rukhsana Satar, Shakeel Ahmed Ansari
CNS & Neurological Disorders - Drug Targets (2024) Vol. 23, Iss. 10, pp. 1251-1262
Closed Access | Times Cited: 5
Selenium Nanoparticles as Neuroprotective Agents: Insights into Molecular Mechanisms for Parkinson’s Disease Treatment
Suganiya Umapathy, Ieshita Pan, Praveen Kumar Issac, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 5
Nanotechnology in Parkinson’s Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes
Irfan Ali, Mohammad Adil, Mohammad Imran, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Nanotools for Screening Neurodegenerative Diseases
Bakr Ahmed Taha, Mohd Hadri Hafiz Mokhtar, Retna Apsari, et al.
(2023), pp. 251-266
Closed Access | Times Cited: 10
Amyloid –β pathology in Alzheimer’s disease: A nano delivery approach
Meghana Goravinahalli Shivananjegowda, DV Gowda, Saravana Babu Chidambaram, et al.
Vibrational Spectroscopy (2023) Vol. 126, pp. 103510-103510
Closed Access | Times Cited: 6
From experimental studies to computational approaches: recent trends in designing novel therapeutics for amyloidogenesis
Pooja Ghosh, Aritra Kundu, Debabani Ganguly
Journal of Materials Chemistry B (2024)
Closed Access | Times Cited: 2
Nanophytosomes: a novel approach for the delivery of herbal drugs
Carlos Martins‐Gomes, Eliana B. Souto, Amélia M. Silva
Elsevier eBooks (2022), pp. 239-257
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top